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Studies in both rodents and humans have shown that acute inflammatory pain experienced
during the perinatal period produces long-term decreases in pain sensitivity (hypoalgesia)
(Grunau et al., 1994a, 2001; Ren et al., 2004; LaPrairie and Murphy, 2007). To date, the
mechanisms underlying these long-term adaptations, however, have yet to be elucidated. The
present studies tested the hypothesis that neonatal inflammatory pain induces an upregulation
in endogenous opioid tone that is maintained into adulthood, and that this increase in opioid
tone provides the underlying mechanism for the observed hypoalgesia. On the day of birth
(P0), inflammatory pain was induced in male and female Sprague-Dawley rats by intraplantar
administration of carrageenan (CGN; 1%). In adulthood (P60), these animals displayed
significantly increased paw withdrawal latencies in response to a noxious thermal stimulus
in comparison to controls. Systemic administration of the brain-penetrant opioid receptor
antagonist naloxone HCl, but not the peripherally restricted naloxone methiodide, significantly
attenuated the injury-induced hypoalgesia. Direct administration of naloxone HCl or antagonists
directed at the mu or delta opioid receptors into the midbrain periaqueductal gray (PAG) also
significantly reversed the injury-induced hypoalgesia in adult rats. Parallel anatomical studies
revealed that inflammatory pain experienced on the day of birth significantly increased betaendorphin and met/leu-enkephalin protein levels and decreased opioid receptor expression in the
PAG of the adult rat. Thus, early noxious insult produces long-lasting alterations in endogenous
opioid tone, thereby profoundly impacting nociceptive responsiveness in adulthood.
Keywords: neonate, inflammation, pain, mu receptor, delta receptor, naloxone

INTRODUCTION
The impact of neonatal pain on developing nociceptive circuitry,
nociceptive processing and the subsequent perception of pain has
been the focus of a significant amount of research within the last decade. Evidence from clinical and animal research suggests that exposure
to noxious stimuli early in life may result in lasting changes in sensory processing (Grunau et al., 1994a; Ren et al., 2004; LaPrairie and
Murphy, 2007). For example, in preterm infants, a higher frequency
of invasive procedures is associated with significantly dampened
pain responses at 32 weeks of age (Grunau et al., 2001). Moreover,
premature infants with NICU experience display decreased behavioral responses to heel-lance and inoculation at 8 months (Johnston
et al., 1996; Oberlander et al., 2000), and are rated by parents as less
sensitive to pain compared to children with no NICU experience
at 18 months of age (Grunau et al., 1994b). Indeed, alterations in
nociception are not transient in nature, such that both full- and
preterm infants with prior NICU experience display decreased pain
sensitivity at 14 years of age (Hermann et al., 2006).
Consistent with the human literature, experimental animal
studies have also shown that neonatal noxious insult induces
widespread changes in nociceptive processing. For example, in rats,
neonatal intraplantar inflammation induces long-lasting and significant hypoalgesia in both the previously injured and uninjured
paws, and changes in pain sensitivity have been reported for the
tail and viscera as well (Al-Chaer et al., 2000; Ren et al., 2004; Wang
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et al., 2004; DeBerry et al., 2007; LaPrairie and Murphy, 2007).
A generalized decrease in nociceptive sensitivity as a consequence of
repetitive foot shock, surgical incisions, and intraplantar formalin
injections has also been reported (Shimada et al., 1990; Bhutta et al.,
2001; Sternberg et al., 2005). In addition, neonatally injured rats
display a hypersensitive response following re-injury in adulthood
and a significantly reduced rate of recovery, with similar findings
reported in humans (Ren et al., 2004; LaPrairie and Murphy, 2007).
Interestingly, all of these long-term consequences associated with
neonatal inflammatory insult are exacerbated in females (LaPrairie
and Murphy, 2007). To date, however, the mechanisms underlying
neonatal injury-induced changes in sensory processing have yet to
be elucidated.
The objective of the present study was to determine if the longterm decreases in nociceptive responsiveness induced by neonatal
inflammatory insult are due to alterations in endogenous pain modulation. Behavioral and anatomical studies were conducted to test
our hypothesis that neonatal injury-induced hypoalgesia is mediated by an increase in central opioid tone resulting from increased
activation of descending nociceptive inhibitory pathways.

MATERIALS AND METHODS
SUBJECTS

Time-pregnant Sprague-Dawley rats (Zivic Miller) were obtained
on the 14th day of gestation (E14) and housed individually. Animals
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were maintained on a 12:12 h light:dark cycle, with food and water
available ad libitum. All litters were reared identically, weaned at
P21, and housed with same-sex littermates in groups of 2–3. All
experiments were approved by the Georgia State University Animal
Care and Use Committee and were conducted in strict compliance
with the guidelines for pain research established by the International
Association for the Study of Pain (IASP).
EARLY LIFE MANIPULATIONS

Acute neonatal inflammation was induced by unilateral injection
of carrageenan (CGN; 1% soln in saline; 5 µl; Sigma, St. Louis MO)
into the plantar surface of the right hindpaw within 12 h of birth on
P0. This inflammatory agent provides a well-established model of
acute local inflammatory pain that persists for 12–72 h (Ren et al.,
2004). Control animals received intraplantar sterile saline or were
“handled” in a similar manner and returned to their home cage.
NOCICEPTIVE BEHAVIORAL TESTING

Thermal testing was conducted using the Paw Thermal Stimulator
(UCSD, San Diego, CA, USA). Briefly, animals were placed in a clear
plastic testing chamber on a glass surface and allowed to acclimate
for a minimum of 30 min prior to testing. A radiant beam of light
beneath the glass base was directed at the plantar surface of the each
hindpaw and the withdrawal reflex latency was electronically measured (in seconds) (Hargreaves et al., 1988). Intact male and cycling
female rats were tested separately. The average withdrawal latency of
three trials was taken; all trials were separated by a 5-min inter-trial
interval. Application of the thermal stimulus to either the left (previously uninjured) or right (previously injured) paw was randomly
determined. While hypoalgesia is present in both paws (LaPrairie
and Murphy, 2007), only right paw latencies are reported here. To
avoid potential tissue damage, a 20-s automatic termination of the
heat stimulus (approximately 2× baseline latency) was imposed if a
paw withdrawal did not occur. The testing apparatus was thoroughly
cleaned between sessions. The same investigator whom was blinded
to the neonatal treatment conducted all behavior tests.
DRUG ADMINISTRATION

To test the hypothesis that neonatal injury-induced hypoalgesia was
due to increased endogenous opioid tone, naloxone HCl (1 mg kg
s.c.; Sigma, St. Louis, MO, USA) dissolved in saline to desired concentration was administered 10 min prior to paw withdrawal latency
(PWL) determination on P60. To test whether alterations in opioid
tone were peripherally mediated, the peripherally restricted opioid
antagonist, naloxone methiodide (1 mg/kg s.c.; Sigma, St. Louis,
MO, USA), was administered systemically 15 min prior to testing
in adulthood. The doses used were selected based on our previous
studies (Ji et al., 2006; LaPrairie and Murphy, 2007).
For intracerebroventricular (i.c.v.) or intra-PAG injections, intact
males (n = 48) and cycling females (n = 52) were deeply anesthetized with a cocktail of ketamine/xylazine/acepromazine (50 mg/
kg/3.3 mg/kg/3.3 mg/kg; i.p.; Henry Shein, Melville, NY, USA)
and placed in a stereotaxic frame. A guide cannula (22G, C313G,
PlasticOne Inc, Roanoke, VA, USA) was implanted at the following
coordinates (mm) for i.c.v. injections: Bregma: −1.0; mediolateral:
1.4; dorsoventral: 3.6. For PAG injections, a guide cannula was
implanted at the following coordinates: lambda: +0.50; mediolateral:
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0.65; dorsoventral: 5.8 as previously described (Loyd et al., 2008).
PAG injections were unilateral, with the cannula located ipsilateral
to the injured paw (right side). The ventrolateral PAG was targeted
for injection as this region contains a high density of mu opioid
receptors (Wang and Wessendorf, 2002).
On P60, naloxone HCl was injected i.c.v. (1.0 µg/2.0 µl; Sigma,
St. Louis, MO, USA) over a 2-min period. In subsequent experiments
the following opioid antagonists were administered intra-PAG:
naloxone (0.5 µg/0.5 µl), mu antagonist CTOP (0.5 µg/0.5 µl
and 7.5 µg/0.5 µl), delta antagonist naltrindole (0.5 µg/0.5 µl and
7.5 µg/0.5 µl) and kappa antagonist nor-BNI (7.5 µg/0.5 µl). All
antagonists were gifts from NIDA. Mu and delta antagonists and
doses were administered in random order 15 min prior to testing.
As nor-BNI is a permanent antagonist, all animals received this
antagonist last (Craft et al., 2001). As a positive control, a separate
group of animals were only administered nor-BNI. Nor-BNI was
administered and testing followed 24 h later (Craft et al., 2001). Paw
withdrawal latencies in response to noxious thermal stimulation
were determined at 15, 30, 45, 60, 90 and 120 min post-injection.
A minimum 72-h washout period between all drugs and doses
was imposed. Injection sites were determined by administration
of Pontamine Sky Blue (0.5 µl, PAG; 2.0 µl, i.c.v.; Sigma Aldrich,
USA) at the completion of the experiment. Brains were removed,
sectioned, and sections mounted onto slides; all injections sites
were verified histologically. Only animals with injection sites into
the lateral ventricle or ventrolateral PAG (Bregma: −7.64 to −8.30)
were used for further analysis.
PERFUSION FIXATION

At P60, a separate group of neonatally manipulated animals that
were not used in the behavioral experiments were given a euthanizing dose of Nembutal (160 mg/kg; i.p.), and then perfused transcardially (descending aorta clamped) with 200 ml of 0.9% sodium
chloride containing 2% sodium nitrite as a vasodilator, followed
by 250 ml of 4% paraformaldehyde in 0.1 M phosphate buffer
containing 2.5% acrolein (Polysciences, Warrington, PA, USA).
Following fixation, a final rinse with the sodium chloride/sodium
nitrite solution was used to remove residual acrolein from the animal. Immediately after perfusion, the brains were removed and the
tissue stored at 4°C in 30% sucrose solution until sectioned. The
brains were cut into 30-µm coronal sections with a Leica 2000R
freezing microtome (Leica Microsystems, Wetler, Germany) and
stored freely floating in cryoprotectant-antifreeze solution (Watson
et al., 1986) at −20°C until immunohistochemical processing.
IMMUNOCYTOCHEMISTRY

A 1:6 series through the rostrocaudal axis of each brain was
processed for immunohistochemical localization of mu opioid
receptor, beta-endorphin, met-enkephalin or leu-enkephalin.
Briefly, sections were removed from the cryoprotectant-antifreeze
solution, rinsed extensively in potassium phosphate-buffered
saline, and then reacted for 20 min in 1% sodium borohydride
to remove excess aldehydes. Sections were then incubated in primary antibody solution in potassium phosphate buffer solution
(KPBS) containing 0.1% Triton X for 1 h at room temperature,
followed by 48 h at 4°C. Mu immunoreactivity was identified
using the polyclonal rabbit anti-MOR antibody at a concentration
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of 1:35,000 (Chemicon; Billerica, MA, USA). Beta-endorphin
immunoreactivity was recognized using the polyclonal rabbit antibeta-endorphin antibody at a concentration of 1:30,000 (Peninsula
Labs; Torrance, CA, USA). Met- and leu-enkephalin immunoreactivity were identified using the polyclonal rabbit anti-met-enkephalin
and anti-leu-enkephalin antibodies at concentrations of 1:50,000
(Immunostar; Hudson, WI, USA) and 1:200,000 (Immunostar;
Hudson, WI, USA), respectively. After rinsing in KPBS, the tissue
was incubated for 1 h in biotinylated goat-anti-rabbit IgG (Jackson
Immunoresearch, West Grove PA, USA; 1:200), rinsed again, and
incubated for 1 h in avidin-biotin peroxidase complex (ABC Elite
Kit, Vector, Burlingame, CA, USA; 1:10). After rinsing in KPBS and
sodium acetate (0.175 M; pH 6.5), antigens were visualized using
nickel sulfate-intensified 3,3′-diaminobenzidine solution containing 0.08% hydrogen peroxide in sodium acetate buffer. The reaction product was terminated after 20–30 min by rinsing in sodium
acetate buffer. Sections were mounted out of saline onto gelatinsubbed slides, air dried overnight, dehydrated in a series of graded
alcohols, cleared in xylene, and coverslipped with Permount.
DENSITOMETRY

The PAG was divided into three rostrocaudal levels: (Rostral: Bregma
−6.72 to −7.04; Mid: Bregma −7.30 to −8.00; Caudal: Bregma −8.30
to −8.80), and the lateral/ventrolateral PAG (PAGl/vl) was analyzed
for each section as previously described (Loyd et al., 2008). The
lateral/ventrolateral region was targeted based on previous studies
demonstrating that this region contains a high density of MOR
mRNA and protein (Commons et al., 2000; Wang and Wessendorf,
2002). Briefly, 12-bit grayscale images of each section were captured
with a 2×, 4× and 20× objective on a Nikon Eclipse E800 microscope using a Sensys digital camera (Biovisions Technology; Exton,
PA, USA). Quantitative analysis was performed using IP Spectrum
software (Scanalytics; Fairfax, VA, USA). The PAGl/vl was sampled
for three sections per animal and the average grayscale pixel value
(ODU; optical density units) was recorded per rostrocaudal level.
Measures were corrected for nonspecific binding by subtraction of
background measures taken from areas lacking immunoreactivity
adjacent to the PAGl/vl.
RECEPTOR AUTORADIOGRAPHY

Neonatally manipulated male and female rats were sacrificed on P60 by
decapitation. Brains were quickly removed, flash-frozen on dry ice and
stored at −80°C. Next, brains were sectioned at 20 µm thickness with a
Leica CM3050S cryostat, and immediately mounted onto Super-frost
slides and stored at −80°C until the time of assay. For radiographical
processing, sections were allowed to thaw to room temperature and
then immersed in 0.1% paraformaldehyde for 2 min to optimize tissue
integrity. Sections then were rinsed in 50 mM Tris-NaCl (pH 7.4) at
room temperature for 15 min followed by a 15-min rinse in 50 nM
Tris (pH 7.4). Next, the tissue sections were incubated for 60 min at
room temperature in a solution of 50 mM Tris (pH 7.4) with 10 mM
MgCl2 and 0.1% bovine serum albumin. 3 nm [3H]-Naltrindole
(20 Ci/mmol; NIDA) was added to label delta receptor binding or
1 nm [3H]-DAMGO (56.8 Ci/mmol; Perkin Elmer/NEN, MA, USA)
was added to label mu receptor binding. Following incubation, sections were washed three times at 10 min each in 50 mM Tris-HCl
(pH 7.4) with 10 mM MgCl2 at room temperature, followed by a final
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dip in cold dH2O. Sections were allowed to air-dry overnight and were
then apposed to FujiFilm imaging plates along with [3H]-microscale
standards (Perkin-Elmer/NEN, MA, USA) for 4 weeks. Film plates
were processed using a FujiFilm BAS 5000. Autoradiographic [3H]receptor binding was quantified from film using MultiGauge software
(FujiFilm, USA). [3H]-standards were used to convert uncalibrated
optical density to disintegrations per minute (DPM). For analysis, the
PAG was divided into three rostrocaudal levels as described above,
and DPM were determined for the lateral/ventrolateral subdivision
of each level. A mean for each level (rostral, mid, caudal) for each
animal was then calculated.
STATISTICAL ANALYSIS AND DATA PRESENTATION

All values are reported as Mean ± SEM. Behavioral data are
expressed as raw withdrawal latencies. Significant main effects
of neonatal treatment and sex were assessed using ANOVA or
Repeated Measures ANOVA; p < 0.05 was considered statistically significant. Sheffe post-hoc tests were conducted to determine significant mean differences between groups that were
apriori specified. Anatomical data are expressed either as optical
density units (ODU; immunohistochemistry) or disinigrations
per minute (DPM; autoradiography). For data presentation, a
representative animal from each experimental group was selected.
Photomicrographs were generated using a Synsys digital camera
attached to a Nikon Eclipse E800 microscope. Images were captured with IP Spectrum software and finalized in Adobe Photoshop
7.0. Alterations to the images were strictly limited to enhancement
of brightness and contrast.

RESULTS
NEONATAL INJURY ALTERS OPIOID TONE

To test the hypothesis that neonatal injury results in upregulated opioid tone in adulthood, neonatally manipulated male
and female rats received a systemic injection of the non-selective
opioid antagonist naloxone HCl (1 mg/kg; i.p.) or saline control
15 min prior to behavioral testing at P60. Neonatally injured
(1% CGN) animals that were administered saline (n = 6–8/sex)
in adulthood displayed significantly increased PWLs compared to
control animals (F(5,39) = 53.54, p < 0.05; Figure 1A). This injuryinduced hypoalgesia was significantly greater in neonatally-injured
females compared to males, as previously reported (LaPrairie and
Murphy, 2007). In contrast, neonatally injured males and females
(n = 6–8/sex) that received systemic naloxone HCl in adulthood
displayed PWLs of approximately 9–10 s, not significantly different
from withdrawal latencies in uninjured control animals (p > 0.05;
Figure 1A). Indeed, opioid receptor blockade by systemic naloxone
completely reversed the neonatal injury-induced hypoalgesia in
both males and females, suggesting that the long-term hypoalgesia
observed in neonatally injured animals is due to altered endogenous
opioid tone.
ALTERATIONS IN OPIOID TONE ARE CENTRALLY, AND NOT
PERIPHERALLY, MEDIATED

Opioid receptors are present both centrally and peripherally (Hiller
et al., 1994). To determine whether changes in peripheral opioid
tone contributed to effects observed with systemic naloxone HCl,
adult animals were administered the peripherally restricted opioid
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FIGURE 1 | (A) Administration of naloxone HCl to neonatally injured animals
(CGN/NAL) prior to testing at P60 significantly lowered PWLs in comparison to
injured animals that received saline (CGN/SAL). Administration of naloxone HCL to
saline (SAL/NAL) or handled (HAN/NAL) controls had no effect. (B) Administration
of naloxone methiodide (NAL-M) to neonatally injured (CGN/NAL-M) animals at
P60 had no significant effect on PWLs compared to injured animals that received
saline (CGN/SAL). Neonatally injured animals (CGN/NAL-M and CGN/SAL)
displayed significantly higher PWLs compared to saline (SAL/NAL-M and

antagonist naloxone methiodide (1 mg/kg) prior to behavioral
testing. This dose has been previously shown to block the peripheral but not central effects of morphine (Ji et al., 2006).
Administration of the naloxone methiodide had no effect on
neonatal injury-induced hypoalgesia (Figure 1B). In contrast,
intracerebroventricular administration of naloxone HCl (1 µg/2 µl),
significantly decreased PWLs in neonatally injured animals to
control levels at 30-min post-administration (F(12,132) = 15.87,
p < 0.05; Figure 1C). Withdrawal latencies in injured animals
returned to pre-injection levels 120-min following administration
of naloxone HCl. In contrast, i.c.v. naloxone HCl had no effect
on withdrawal latencies in handled and saline control animals.
Together, these results suggest that neonatal inflammation results
in persistent changes in opioid tone that are centrally mediated.
CHANGES IN OPIOID TONE ARE MEDIATED WITHIN THE PAG

The PAG is an essential substrate for opioid-induced analgesia
(Basbaum and Fields, 1978, 1984; Fields et al., 1991). To test the
hypothesis that neonatal injury-induced alterations in opioid tone
were mediated within the PAG, we administered naloxone HCl directly
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SAL/SAL) and handled (HAN/NAL-M and HAN/SAL) controls. (C) Neonatally injured
males (z) and females ({) displayed significantly reduced PWLs during the
120 min following i.c.v. or (D) intra-PAG administration of naloxone HCl compared
to handled males (S) or females (U) and saline males () and females ( ).
N = 6–8 rats per group/per sex. In panels (A) and (B): * denotes significant main
effect of treatment; # denotes significant main effect of sex; in panels (C) and
(D) – * indicates that PWLs for injured animals (collapsed across sex) were
significantly different from controls. Error bars represent SEM.

into the mid ventrolateral PAG (PAGvl) in neonatally injured and
control animals. Intra-PAGvl naloxone (0.5 µg/0.5 µl) significantly
reduced PWLs in neonatally injured males and females at 15 min
post-injection (F(12,144) = 8.95, p < 0.05; Figure 1D). No effect of
intra-PAGvl naloxone was noted on PWLs in control animals.
The PAG contains mu, delta and kappa receptors (Mansour et al.,
1995); therefore, to determine which opioid receptor subtype(s) in the
PAG contribute to alterations in opioid tone, we administered receptor specific opioid antagonists. Intra-PAGvl administration of the mu
receptor antagonist, CTOP (7.5 µg/0.5 µl) significantly reduced PWLs
in injured males and females to a level comparable to control values at
30 min post-injection (F(12,108) = 9.21, p < 0.05; Figure 2A). IntraPAGvl naltrindole (7.5 µg/0.5 µl), a delta-selective antagonist, also
significantly decreased PWLs to control levels, but only in neonatally
injured females (F(12,144) = 2.92, p < 0.05; Figure 2B). In males, the
effects of intra-PAGvl naltrindole were limited to the first 15 min
post-injection, with only a slight, albeit significant, decrease in PWLs
observed. Intra-PAGvl administration of nor-BNI did not significantly
reduce withdrawal latencies in injured males or females: significant
main effect of injury, F(2,42) = 474.25, p < 0.05; Figure 2C.
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ventrolateral PAG. No significant injury effects were observed in
the rostral PAG. Moreover, no significant sex differences in betaendorphin expression were detected at any level of the PAG.
Neonatal injury also induced changes in the expression of the
DOR preferring ligands, met-and leu-enkephalin. Specifically, neonatally injured males and females displayed significantly increased
met- and leu-enkephalin immunoreactivity in the l/vl region of the
mid (met: F(1,20) = 29.50, p < 0.05; leu: F(1,20) = 14.92, p < 0.05)
and caudal (met: F(1,20) = 50.88, p < 0.05; leu: F(1,20) = 13.23,
p < 0.05) levels of the PAG compared to controls (Figure 4). For
both met- and leu-enkephalin, neonatal injury induced an increase
in both the number and density of fiber staining; changes in immunoreactivity were primarily limited to the lateral PAG. A significant effect of sex was noted within the mid and caudal PAGl/vl for
met-enkephalin, such that injured females displayed significantly
more immunoreactive fibers compared to injured males (mid:
F(1,20) = 5.39, p < 0.05; caudal: F(1,20) = 4.72, p < 0.05).
DECREASED MOR AND DOR BINDING IN THE PAG

FIGURE 2 | (A) Intra-PAGvl CTOP significantly reduced PWLs in neonatally
injured males (z) and females ({) compared to controls. (B) Neonatally
injured females displayed significantly reduced PWLs following intra-PAGvl
naltrindole that were not significantly different from handled and saline
controls. In males, intra-PAGvl naltrindole resulted in a slight decrease in
PWLs. (C) Administration of nor-BNI into the PAGvl had no significant effect on
PWLs in neonatally injured or control animals. N = 6–8 rats per group/per sex.
* indicates that PWLs for injured animals (collapsed across sex) were
significantly different from controls.

We next used autoradiography to determine if neonatal injury
was also associated with changes in opioid receptor binding.
Neonatally injured males and females displayed significantly
reduced MOR binding at all rostral-caudal levels of the PAGl/vl
compared to handled controls (rostral: F(1,20) = 58.46, p < 0.05;
mid: F(1,20) = 286.50, p < 0.05; caudal: F(1,20) = 78.89, p < 0.05;
Figure 5). Immunohistochemistry was also used to confirm our
observed decrease in PAG MOR expression. Similar to what we
observed using autoradiography, neonatal injury resulted in a
significant decrease in MOR immunoreactivity (primarily due
to decreased fiber staining) within the mid (F(1,20) = 26.34,
p < 0.05) and caudal (F(1,20) = 31.51, p < 0.05) levels of the
PAGl/vl (Figure 6). Neonatal injury induced decreases in MOR
were also evident within the dorsolateral PAG.
A significant decrease in DOR binding was also observed at the
mid level (F(1,20) = 22.41, p < 0.05) of the PAGl/vl in neonatally
injured females compared to all other groups (Figure 5). The sexually dimorphic expression of DOR binding in injured animals is
consistent with our behavioral effects showing sex-specific effects of
intra-PAG naltrindole on baseline thermal sensitivity (Figure 2B).
As there are no DOR-specific antibodies that are commercially
available, corroboration of the binding data with immunocytochemistry could not be performed.

DISCUSSION
INJURY-INDUCED INCREASE BETA-ENDORPHIN AND
MET/LEU-ENKEPHALIN IMMUNOREACTIVITY IN THE PAG

The next series of experiments used immunohistochemistry and
receptor autoradiography to determine whether our behavioral
pharmacological results reflected changes in endogenous opioid
peptide and/or receptor expression within the PAG.
Beta-endorphin, an endogenous opioid neuropeptide that has the
highest affinity for mu opioid receptors, was significantly increased
in the lateral/ventrolateral (l/vl) region of the mid (F(1,16) = 4.62,
p < 0.05) and caudal (F(1,16) = 6.57, p < 0.05) PAG in neonatally injured males and females compared to handled controls
(Figure 3). Increases in beta-endorphin were primarily evidenced
as an increase in the number of immunoreactive fibers within the
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Our principle finding is that the hypoalgesia induced by neonatal inflammatory insult is mediated by changes in mu and delta,
but not kappa, opioid tone within the PAG, as indicated by an
increase in endogenous opioid peptide expression (beta-endorphin
and met/leu-enkephalin), and a concomitant decrease in mu and
delta opioid receptor binding. Changes in delta opioid tone were sex
specific, and may contribute to the potentiated effects of neonatal
injury observed in females.
The periaqueductal gray (PAG), and its descending projections to the rostral ventromedial medulla (RVM) and the spinal
cord dorsal horn, constitute a primary anatomical circuit for the
descending modulation of pain (Basbaum and Fields, 1984). The
PAG is rich in nerve terminals and fibers containing endogenous
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FIGURE 3 | Photomicrograph depicting representative examples of beta-endorphin-ir in the PAGl/vl in adult rats following neonatal treatment.
(A) handled, 4×, (B) handled, 20×; (C) 1% carrageenan, 20×. (D) Neonatal CGN resulted in significantly increased beta-endorphin-ir in the lateral/ventrolateral regions
of the mid and caudal PAG compared to control animals. N = 6–8 rats per group/per sex. * denotes significant main effect of treatment. Error bars represent SEM.

opioids (Reichling et al., 1988), and opioid receptors are localized
throughout the rostral-caudal axis of the PAG (Mansour et al.,
1995). Interestingly, while in rats the anatomical connections for
nociceptive modulation are present at birth, descending inhibitory
controls are functionally immature throughout the first postnatal
weeks (Fitzgerald and Koltzenburg, 1986; Boucher et al., 1998).
The delayed maturation of descending inhibition may therefore
contribute to the increased vulnerability of the immature somatosensory system to excessive afferent input, whereby exposure to
neonatal noxious stimulation during a critical window may alter
the functional integrity of endogenous descending inhibitory systems. In reference to the present results, our working hypothesis is
that neonatal injury during this critical developmental period (P0–
P8; LaPrairie and Murphy, 2007) results in increased afferent drive
to CNS sites responsive to noxious input (e.g. PAG). This increased
drive results in the activation of endogenous pain inhibitory circuits and the subsequent release of endogenous opioid peptides.
As the inflammation associated with intraplantar carrageenan is
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persistent (lasting approximately 48–72 h), the release of endogenous opioids is sustained, and this continuous opioid release, during a time of increased developmental plasticity, is subsequently
maintained into adulthood. Previous studies have reported that
increased afferent drive during the developmental critical period
results in the reorganization of somatosensory circuits in adulthood (Tropea et al., 2006). Indeed, changes in endogenous pain
modulation in humans as a consequence of neonatal pain has been
previously proposed to account for the long term changes in pain
sensitivity observed in NICU infants exposed to frequent noxious
interventions (Goffaux et al., 2008).
In the present study, we report a significant increase in PAG opioid
peptide expression as a consequence of neonatal injury, and it is
notable that alterations in the endorphin and enkephalinergic systems were very well correlated across similar regions and levels of the
PAG. This suggests that the two opioidergic systems act in parallel in
response to neonatal inflammation and nociception. While comparable studies have not been conducted in neonates, previous studies
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FIGURE 4 | Photomicrograph depicting met- and leu-enkephalin-ir at mid-level PAG in adult rats following neonatal handling (A,C) or intraplantar
CGN (B,D). A significant increase in met- and leu-enkephalin-ir (panels E and F, respectively) was noted in neonatally-injured animals compared to controls at all
rostral-caudal levels of the PAG. N = 6–8 rats per group/per sex. * denotes significant main effect of treatment; # denotes significant main effect of sex. Error bars
represent SEM.
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FIGURE 5 | MOR binding in the PAG in adult rats following (A) handling,
or (B) 1% carrageenan. DOR binding distribution in the PAG of adult rats
following (C) handling, or (D) 1% carrageenan. (E) Neonatally injured (CGN)
animals displayed a significant decrease in MOR-binding at all levels of the
PAGl/vl compared to handled animals. (F) A significant decrease in

in adult rats have reported that hindpaw inflammation results in
upregulated biosynthesis of pro-dynorphin and pro-enkephalin in
dorsal horn neurons (Iadarola et al., 1988; Noguchi et al., 1989), and
a significant increase in endogenous opioid peptide release within the
PAG (Williams et al., 1995). Noxious stimulation-induced changes
in opioid peptide expression are also paralleled by an increase in
mRNA expression (Iadarola et al., 1988). As stated above, our working hypothesis is that neonatal inflammation results in the release
of endogenous opioid peptides within the PAG as a mechanism
of decreasing nociception. It is not clear why a parallel decrease in
opioid receptor expression was also noted. However, previous studies
have similarly reported a long-term increase in endogenous opioid
peptide along with a concomitant decrease in mu and delta opioid
receptor density in the lateral hypothalamus of offspring following
gestational stress (Sanchez et al., 1996, 2000). Alternatively, opioid
receptors are rapidly internalized following ligand binding, which
would also result in a concomitant decrease in opioid receptor availability. Taken together, these studies suggest that early life pain can
confer long-lasting changes in supraspinal opioidergic circuits that
are reflected by changes in peptide and receptor expression.
In the present study, intra-PAG naloxone significantly reduced
neonatal injury-induced hypoalgesia suggesting a locus for injuryinduced changes. However, neonatal inflammatory insult may
induce changes in opioid tone in other sites, including the RVM and
spinal cord. Indeed, increased brain and spinal cord immunoreactive
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DOR-binding was noted in neonatally injured females in comparison to all
other groups in the mid PAGl/vl. A significant main effect of sex was also
observed at this level. N = 6 rats per group/per sex. * denotes significant main
effect of treatment; # denotes significant main effect of sex. Error bars
represent SEM.

beta-endorphin, met-enkephalin and dynorphin, as well as decreased
opioid receptor binding has been reported following peripheral
inflammation in adult rats (Cesselin et al., 1980; Millan et al., 1986;
Spetea et al., 2002). Therefore, while the results of our site-specific
antagonist injections suggest that changes in the PAG are necessary
and sufficient for the observed effects of neonatal injury, changes in
additional CNS sites cannot be excluded.
A significantly greater increase in met-enkephalin was observed in
neonatally injured females compared to males. This differential change
in peptide expression may contribute to the increased hypoalgesia
observed in females. No significant sex difference in met-enkephalin
immunoreactivity was present at baseline, indicating that the observed
sex differences were injury-induced. Although not investigated in the
present study, endomorphins also play an important role in the modulation of descending controls, and possess partial agonist properties
at mu-receptor sites in the PAG (Zadina et al., 1997).
While the results of the present study strongly suggest that
persistent alterations in baseline nociceptive thresholds associated with neonatal inflammatory insult are mediated by a central
increase in endogenous opioid tone, additional mechanisms may
also contribute. Noxious neonatal experiences lead not only to
decreased nociceptive sensitivity in adulthood, but also to significant alterations in the behavioral and neuroendocrine responses to
stress (Bernardi et al., 1986; Anand et al., 1999; Bhutta et al., 2001;
Schellinck et al., 2003; Sternberg and Ridgway, 2003; Sternberg et al.,
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FIGURE 6 | Photomicrograph depicting representative examples of MOR-ir
in the PAGl/vl in adult rats following neonatal treatment. (A) handled, 4×,
(B) handled, 10×, (C) 1% carrageenan, 10×. (D) At mid and caudal levels of PAG,

2005). Blunted emotionality, decreased anxiety, and reduced basal
and stress induced plasma corticotropin releasing factor (CRF) and
adrenocorticotropin hormone (ACTH) are displayed in adult rats
following short-lasting, local inflammation experienced during the
first week of life (Bhutta et al., 2001; Anseloni et al., 2005). Premature
infants with extensive NICU care also exhibit low basal levels of
stress hormones at 3 months of age compared to their full-term
counterparts (Grunau et al., 2007). Thus, alterations in the developing hypothalamic–pituitary–adrenal axis may also contribute to the
long-term basal hypoalgesia following neonatal hindpaw inflammation. Indeed neonatal noxious stimulation may produce a generalized reduction in reactivity to aversive environmental stimuli due to
parallel alterations in supraspinal nociceptive and stress modulatory
circuits (Ren et al., 2004; Anseloni et al., 2005). Ongoing studies in
our laboratory are currently testing this hypothesis.
In summary, the present study demonstrated that persistent
pain experienced early in life results in decreased mu and delta
receptor availability, suggesting a persistent activation of opioid
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CGN animals expressed significantly lower MOR-ir compared to handled
animals. N = 6–8 rats per group/per sex. * denotes significant main effect of
treatment. Error bars represent SEM.

receptors due to enhanced release of endogenous opioid peptides.
This decrease in receptor availability is supported by our previous
findings demonstrating a significant rightward shift in the morphine dose-response curve in adult animals that were neonatallyinjured (LaPrairie et al., 2008). Similar results have been reported in
children, such that the number of invasive procedures experienced
in the neonatal intensive care unit are inversely correlated with
morphine effectiveness (Grunau et al., 2001). Despite the current
knowledge that neonates are responsive to noxious stimuli, the
majority of routine procedures, including repeated heel-lances,
endotracheal intubations and minor surgeries are performed in
the absence of analgesics (Simons et al., 2003). Indeed recent studies have reported that neonates receiving NICU treatment experience an average of 14 noxious procedures per day, with fewer than
35% receiving appropriate analgesic therapy (Simons et al., 2003).
Demonstration that neonatal injury results in long-term changes in
opioid tone and sensory thresholds may have serious implications
for future pain management in neonates.
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